Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eliapixant in Diabetic Neuropathic Pain
NCT04641273Phase 2Terminated
- Sponsor
- Bayer
- Start
- Jan 2021
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 2 trial of eliapixant in neuropathic pain, sponsored by Bayer. Started Jan 2021; status: terminated.
02
Drugs
eliapixant
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT04641273.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04641273.